Mirae Asset Global ETFs Holdings
OBIO icon

Mirae Asset Global ETFs Holdings’s Orchestra BioMed OBIO Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio OBIO Stock Details OBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-15,043
Closed -$64.4K – 3168
2025
Q1 		$64.4K Buy
15,043
+1,747
+13% +$8.69K ﹤0.01% 2790
2024
Q4 		$53.2K Buy
13,296
+608
+5% +$3.27K ﹤0.01% 2890
2024
Q3 		$65.2K Buy
12,688
+4,553
+56% +$29.7K ﹤0.01% 2859
2024
Q2 		$66.3K Buy
+8,135
New +$47.1K ﹤0.01% 2714

Other funds holding OBIO

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's OBIO Position: Q2 2025 in Review

Mirae Asset Global ETFs Holdings sold out of Orchestra BioMed (OBIO) in Q2 2025, closing a stake of 15,043 shares — an estimated $64.4K sold.

Mirae Asset Global ETFs Holdings first reported a position in OBIO in Q2 2024 and held it in 4 quarters. The position peaked at $66.3K in Q2 2024. 59 funds tracked by Wall St. Rank hold OBIO as of Q2 2025.

  • Mirae Asset Global ETFs Holdings reported no remaining Orchestra BioMed position as of Q2 2025 after selling out during the quarter.
  • Mirae Asset Global ETFs Holdings sold 15,043 Orchestra BioMed shares in Q2 2025, an estimated $64.4K.
  • Mirae Asset Global ETFs Holdings first reported a position in Orchestra BioMed in Q2 2024 and held it in 4 quarters.
  • Mirae Asset Global ETFs Holdings's Orchestra BioMed position peaked at $66.3K in Q2 2024.
  • 59 funds tracked by Wall St. Rank held Orchestra BioMed as of Q2 2025.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2025, filed 14 Aug 2025.